UK BMT Pharmacists’ Group Educational Meeting

The UK BMT Pharmacists’ Group (a special-interest group affiliated to BOPA) is running an educational meeting at University College Hospital (UCH Education Centre, 250 Euston Road, London NW1 2PG) on the afternoon of Friday 13th March.

Although the meeting will have a transplant-focus, we have tried to make the agenda fairly broad, and all pharmacists with an interest in haematology are very welcome to attend.

There is no registration fee and no need to pre-register but it would help from a logistical point of view if you could email: [email protected]  if you are planning to attend

BMT meeting Agenda March 2020

Thanks – Nick Duncan and the BOPA Committee

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article